Table 1.
Effect of Vitamin D supplementation on blood pressure, serum calcium, phosphorus, alkaline phosphatase, albumin, albumin-corrected calcium and 24 h urinary creatinine levels in hypertensive patients
| Parameters | Group I | Group II | ||
|---|---|---|---|---|
| Blood pressure (mmHg) | Before treatment | After 3 months | Before treatment/supplement | After 3 months |
| Diastolic | 78.1 ± 0.69 | 80.2 ± 0.73 | 77.4 ± 0.55 | 78.7 ± 0.55 |
| Systolic | 148.8 ± 0.73 | 145.2 ± 0.83* | 149.1 ± 0.88 | 141.6 ± 0.92*, ** |
| Serum calcium (mg/dl) | 8.75 ± 0.07 | 8.60 ± 0.06 | 8.57 ± 0.03 | 9.33 ± 0.06*, ** |
| Serum phosphorous (mg/dl) | 3.51 ± 0.05 | 3.63 ± 0.04 | 3.57 ± 0.03 | 3.06 ± 0.05*, ** |
| Serum alkaline phosphatase (KAU) | 8.18 ± 0.18 | 7.88 ± 0.17 | 8.14 ± 0.13 | 7.32 ± 0.15 |
| Serum albumin (g/dl) | 3.58 ± 0.04 | 3.50 ± 0.03 | 3.59 ± 0.03 | 3.51 ± 0.03 |
| Albumin-corrected calcium (mg/dl) | 5.0 ± 0.05 | 5.0 ± 0.06 | 4.9 ± 0.03 | 5.4 ± 0.05*, ** |
| 24 h urinary creatinine (mg/dl) | 1465 ± 22.3 | 1502 ± 23.8 | 1482 ± 22.8 | 1484 ± 20.1 |
Values are mean ± SE for 100 patients in each group
* P < 0.05 when compared with the corresponding mean value before treatment
** P < 0.05 when compared with the after 3 month’s mean value of group I